Virginie Guillem-Vlaeminck

Pierre-la-treiche, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Prevalence of Hidradenitis Suppurativa in Lyon: Results from the French Team of the Global Hidradenitis Suppurativa Atlas Project.

Prevalence of Hidradenitis Suppurativa in Lyon: Results from the French Team of the Global Hidradenitis Suppurativa Atlas Project.

Journal: Dermatology (Basel, Switzerland)
Published: April 02, 2024

Can Adalimumab Reduce the Extent of Hidradenitis Suppurativa Surgery?

Can Adalimumab Reduce the Extent of Hidradenitis Suppurativa Surgery?

Journal: JAMA surgery
Published: March 09, 2022

Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.

Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.

Journal: Frontiers in immunology
Published: February 25, 2022

Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).

Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).

Journal: BMJ open
Published: February 10, 2022

Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.

Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.

Journal: Cancers
Published: October 26, 2021

Intermammary Hidradenitis Suppurativa.

Intermammary Hidradenitis Suppurativa.

Journal: Skin appendage disorders
Published: October 12, 2021

Exosomes and prostate cancer management.

Exosomes and prostate cancer management.

Journal: Seminars in cancer biology
Published: May 31, 2021

Non-genomic signaling of steroid receptors in cancer.

Non-genomic signaling of steroid receptors in cancer.

Journal: Molecular and cellular endocrinology
Published: May 25, 2021

The scaffold protein menin is essential for activating the MYC locus and MYC-mediated androgen receptor transcription in androgen receptor-dependent prostate cancer cells.

The scaffold protein menin is essential for activating the MYC locus and MYC-mediated androgen receptor transcription in androgen receptor-dependent prostate cancer cells.

Journal: Cancer communications (London, England)
Published: May 22, 2021

MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.

MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 12, 2021

Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer.

Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer.

Journal: Translational andrology and urology
Published: January 18, 2021

Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway.

Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway.

Journal: Oncogene
Published: June 05, 2020
Showing 1-12 of 35

Last Updated: 09/26/2026